Giant Biogene Holding Co. Ltd. (2367) Stock Forecast & Price Target

Compare

8 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

2367 Analyst Ratings

Strong Buy

13 Buy

0 Hold

0 Sell

Based on 13 analysts giving stock ratings to

Giant

Biogene Holding Co. Ltd.

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

2367 Stock 12 Month Forecast

Average Price Target

HK$60.38

▲(66.80% Upside)

Based on 13 Wall Street analysts offering 12 month price targets for Giant Biogene Holding Co. Ltd. in the last 3 months. The average price target is HK$60.38 with a high forecast of HK$85.00 and a low forecast of HK$44.60. The average price target represents a 66.80% change from the last price of HK$36.20.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"35":"HK$35","86":"HK$86","47.75":"HK$47.8","60.5":"HK$60.5","73.25":"HK$73.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":85,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$85.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":60.38,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$60.38</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":44.6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$44.60</span>\n  </div></div>","useHTML":true}}],"tickPositions":[35,47.75,60.5,73.25,86],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,36.58,40.30461538461538,44.029230769230765,47.753846153846155,51.47846153846154,55.20307692307692,58.92769230769231,62.652307692307694,66.37692307692308,70.10153846153847,73.82615384615384,77.55076923076923,81.27538461538461,{"y":85,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,36.58,38.410769230769226,40.24153846153846,42.07230769230769,43.903076923076924,45.73384615384615,47.56461538461539,49.395384615384614,51.22615384615385,53.05692307692308,54.887692307692305,56.71846153846154,58.549230769230775,{"y":60.38,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,36.58,37.19692307692308,37.81384615384615,38.43076923076923,39.04769230769231,39.66461538461538,40.28153846153846,40.89846153846154,41.51538461538462,42.13230769230769,42.74923076923077,43.36615384615385,43.98307692307692,{"y":44.6,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":47.21,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":48.78,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":55.57,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":61.19,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.62,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.2,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":66.71,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":57.7,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":55.55,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.85,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":56.5,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":37.2,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":36.58,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price TargetHK$85.00

Average Price TargetHK$60.38

Lowest Price TargetHK$44.60

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Unknown Analyst

HSBC

Not Ranked

HSBC

HK$69.3→HK$46.4

Buy

28.18%

Upside

Reiterated

12/05/25

HSBC Sticks to Their Buy Rating for Giant Biogene Holding Co. Ltd. (2367)

Jill Wu

CMB International Securities

HK$58.35→HK$53.89

Buy

48.87%

Upside

Reiterated

12/03/25

CMB International Securities Sticks to Its Buy Rating for Giant Biogene Holding Co. Ltd. (2367)

Tiffany Feng

Citi

HK$55.4→HK$44.6

Buy

23.20%

Upside

Reiterated

12/03/25

Citi Sticks to Its Buy Rating for Giant Biogene Holding Co. Ltd. (2367)

Sunny Chow

Macquarie

HK$61

Buy

68.51%

Upside

Reiterated

12/03/25

Giant Biogene Holding Co. Ltd. (2367) Receives a Buy from Macquarie

Boya Zhen

Jefferies

HK$55

Buy

51.93%

Upside

Reiterated

12/03/25

Jefferies Sticks to Its Buy Rating for Giant Biogene Holding Co. Ltd. (2367)

Unknown Analyst

CICC

Not Ranked

CICC

HK$70→HK$56

Buy

54.70%

Upside

Reiterated

12/03/25

CICC Reaffirms Their Buy Rating on Giant Biogene Holding Co. Ltd. (2367)

Ingrid Zhang

UBS

HK$79.5

Buy

119.61%

Upside

Reiterated

12/02/25

Unknown Analyst

CSC Financial

Not Ranked

CSC Financial

HK$45

Buy

24.31%

Upside

Reiterated

12/02/25

Unknown Analyst

Bank of America Securities

Not Ranked

Bank of America Securities

HK$68.3→HK$55.5

Buy

53.31%

Upside

Reiterated

12/02/25

Bank of America Securities Keeps Their Buy Rating on Giant Biogene Holding Co. Ltd. (2367)

Unknown Analyst

Morgan Stanley

Not Ranked

Morgan Stanley

HK$78

Buy

115.47%

Upside

Reiterated

12/02/25

Giant Biogene Holding Co. Ltd. (2367) Receives a Buy from Morgan Stanley

Callum Elliott

Bernstein

HK$70

Buy

93.37%

Upside

Reiterated

11/12/25

Giant Biogene Holding Co. Ltd. (2367) Receives a Buy from Bernstein

Unknown Analyst

Bank of America Securities

Not Ranked

Bank of America Securities

HK$79.5→HK$68.3

Buy

88.67%

Upside

Reiterated

10/27/25

Unknown Analyst

CICC

Not Ranked

CICC

HK$82→HK$70

Buy

93.37%

Upside

Reiterated

10/24/25

Unknown Analyst

Huatai Securities

Not Ranked

Huatai Securities

HK$85

Buy

134.81%

Upside

Reiterated

10/24/25

Unknown Analyst

Citic Securities

Not Ranked

Citic Securities

HK$77→HK$55

Buy

51.93%

Upside

Reiterated

10/24/25

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Unknown Analyst

HSBC

Not Ranked

HSBC

HK$69.3→HK$46.4

Buy

28.18%

Upside

Reiterated

12/05/25

HSBC Sticks to Their Buy Rating for Giant Biogene Holding Co. Ltd. (2367)

Jill Wu

CMB International Securities

HK$58.35→HK$53.89

Buy

48.87%

Upside

Reiterated

12/03/25

CMB International Securities Sticks to Its Buy Rating for Giant Biogene Holding Co. Ltd. (2367)

Tiffany Feng

Citi

HK$55.4→HK$44.6

Buy

23.20%

Upside

Reiterated

12/03/25

Citi Sticks to Its Buy Rating for Giant Biogene Holding Co. Ltd. (2367)

Sunny Chow

Macquarie

HK$61

Buy

68.51%

Upside

Reiterated

12/03/25

Giant Biogene Holding Co. Ltd. (2367) Receives a Buy from Macquarie

Boya Zhen

Jefferies

HK$55

Buy

51.93%

Upside

Reiterated

12/03/25

Jefferies Sticks to Its Buy Rating for Giant Biogene Holding Co. Ltd. (2367)

Unknown Analyst

CICC

Not Ranked

CICC

HK$70→HK$56

Buy

54.70%

Upside

Reiterated

12/03/25

CICC Reaffirms Their Buy Rating on Giant Biogene Holding Co. Ltd. (2367)

Ingrid Zhang

UBS

HK$79.5

Buy

119.61%

Upside

Reiterated

12/02/25

Unknown Analyst

CSC Financial

Not Ranked

CSC Financial

HK$45

Buy

24.31%

Upside

Reiterated

12/02/25

Unknown Analyst

Bank of America Securities

Not Ranked

Bank of America Securities

HK$68.3→HK$55.5

Buy

53.31%

Upside

Reiterated

12/02/25

Bank of America Securities Keeps Their Buy Rating on Giant Biogene Holding Co. Ltd. (2367)

Unknown Analyst

Morgan Stanley

Not Ranked

Morgan Stanley

HK$78

Buy

115.47%

Upside

Reiterated

12/02/25

Giant Biogene Holding Co. Ltd. (2367) Receives a Buy from Morgan Stanley

Callum Elliott

Bernstein

HK$70

Buy

93.37%

Upside

Reiterated

11/12/25

Giant Biogene Holding Co. Ltd. (2367) Receives a Buy from Bernstein

Unknown Analyst

Bank of America Securities

Not Ranked

Bank of America Securities

HK$79.5→HK$68.3

Buy

88.67%

Upside

Reiterated

10/27/25

Unknown Analyst

CICC

Not Ranked

CICC

HK$82→HK$70

Buy

93.37%

Upside

Reiterated

10/24/25

Unknown Analyst

Huatai Securities

Not Ranked

Huatai Securities

HK$85

Buy

134.81%

Upside

Reiterated

10/24/25

Unknown Analyst

Citic Securities

Not Ranked

Citic Securities

HK$77→HK$55

Buy

51.93%

Upside

Reiterated

10/24/25

Stocks with the Highest Top Analyst Consensus in the Consumer Defensive Sector

xxx

Find stocks in the Consumer Defensive sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Giant Biogene Holding Co. Ltd.

1 Month

xxx

Success Rate

4/5 ratings generated profit

Average Return

+11.56%

reiterated a xxx

rating 10 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 80.00% of your transactions generating a profit, with an average return of +11.56% per trade.

3 Months

xxx

Success Rate

2/4 ratings generated profit

Average Return

-1.10%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -1.10% per trade.

1 Year

Jill WuCMB International Securities

Success Rate

2/9 ratings generated profit

Average Return

-9.89%

reiterated a buy rating 10 days ago

Copying Jill Wu's trades and holding each position for 1 Year would result in 22.22% of your transactions generating a profit, with an average return of -9.89% per trade.

2 Years

xxx

Success Rate

1/9 ratings generated profit

Average Return

-20.63%

reiterated a xxx

rating 10 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 11.11% of your transactions generating a profit, with an average return of -20.63% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

2367 Analyst Recommendation Trends

Rating

Aug 25

Sep 25

Oct 25

Nov 25

Dec 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 2367 has received 19 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. 2367 average Analyst price target in the past 3 months is 60.38.

Each month's total comprises the sum of three months' worth of ratings.

2367 Financial Forecast

2367 Earnings Forecast

Next quarter’s earnings estimate for 2367 is HK$1.25 with a range of HK$1.25 to HK$1.25. The previous quarter’s EPS was HK$1.24. 2367 beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.98% of the time in the same period. In the last calendar year 2367 has Performed in-line its overall industry.

2367 Sales Forecast

Next quarter’s sales forecast for 2367 is HK$4.17B with a range of HK$4.17B to HK$4.17B. The previous quarter’s sales results were HK$3.34B. 2367 beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 52.41% of the time in the same period. In the last calendar year 2367 has Outperformed its overall industry.

2367 Stock Forecast FAQ

What is HK:2367’s average 12-month price target, according to analysts?

Based on analyst ratings, Giant Biogene Holding Co. Ltd.’s 12-month average price target is 60.38.

What is HK:2367’s upside potential, based on the analysts’ average price target?

Giant Biogene Holding Co. Ltd. has 66.80% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Giant Biogene Holding Co. Ltd. a Buy, Sell or Hold?

Giant Biogene Holding Co. Ltd. has a consensus rating of Strong Buy, which is based on 13 buy ratings, 0 hold ratings and 0 sell ratings.

What is Giant Biogene Holding Co. Ltd.’s share price target?

The average share price target for Giant Biogene Holding Co. Ltd. is 60.38. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is HK$85.00 ,and the lowest forecast is HK$44.60. The average share price target represents 66.80% Increase from the current price of HK$36.2.

What do analysts say about Giant Biogene Holding Co. Ltd.?

Giant Biogene Holding Co. Ltd.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 13 Wall Streets Analysts.

How can I buy shares of Giant Biogene Holding Co. Ltd.?

To buy shares of HK:2367, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Giant Biogene Holding Co. Ltd. (2367) Stock Forecast & Price Target

2367 Analyst Ratings

2367 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Giant Biogene Holding Co. Ltd.

2367 Analyst Recommendation Trends

2367 Financial Forecast

2367 Earnings Forecast

2367 Sales Forecast

2367 Stock Forecast FAQ

Detailed List of Analyst Forecasts